Pathstone Family Office’s Inspire Medical Systems INSP Stock Holding History

Pathstone Family Office’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$476K	Buy	2,399 +25	+1%	+$6.3K	﹤0.01%	1062
2023 Q2	$771K	Sell	2,374 -4	-0.2%	-$1.14K	0.01%	567
2023 Q1	$557K	Buy	2,378 +91	+4%	+$23K	0.01%	640
2022 Q4	$576K	Buy	2,287 +14	+0.6%	+$2.98K	0.01%	648
2022 Q3	$403K	Buy	2,273 +59	+3%	+$11.9K	0.01%	776
2022 Q2	$404K	Sell	2,214 -526	-19%	-$105K	0.01%	664
2022 Q1	$703K	Sell	2,740 -12	-0.4%	-$2.74K	0.02%	431
2021 Q4	$633K	Buy	2,752 +25	+0.9%	+$6.1K	0.02%	465
2021 Q3	$635K	Buy	2,727 +160	+6%	+$33.4K	0.02%	433
2021 Q2	$496K	Buy	2,567 +942	+58%	+$187K	0.01%	466
2021 Q1	$336K	Buy	+1,625	New	+$345K	0.01%	453

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Pathstone Family Office's INSP Position: Q3 2023 in Review

Pathstone Family Office increased its Inspire Medical Systems (INSP) stake by 1.1% in Q3 2023, buying an estimated $6.3K and bringing the position to 2,399 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Pathstone Family Office first reported a position in INSP in Q1 2021 and has held it in 11 quarters since. The position peaked at $771K in Q2 2023. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

Pathstone Family Office held 2,399 shares of Inspire Medical Systems worth $476K as of Q3 2023.
Pathstone Family Office bought 25 Inspire Medical Systems shares in Q3 2023, an estimated $6.3K.
Inspire Medical Systems made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1062 holding.
Pathstone Family Office first reported a position in Inspire Medical Systems in Q1 2021 and has held it in 11 quarters since.
Pathstone Family Office's Inspire Medical Systems position peaked at $771K in Q2 2023.
364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.